| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |